Medifast (NYSE:MED) reported its Q4 earnings results on Tuesday, February 20, 2024 at 04:05 PM.
Here’s what investors need to know about the announcement.
Earnings
Medifast beat estimated earnings by 13.54%, reporting an EPS of $1.09 versus an estimate of $0.96.
Revenue was down $146.23 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $1.06 which was followed by a 2.5% drop in the share price the next day.
Here’s a look at Medifast’s past performance:
| Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|
| EPS Estimate | 1.06 | 1.44 | 2.40 | 2.22 |
| EPS Actual | 2.12 | 2.77 | 3.67 | 3.70 |
| Revenue Estimate | 232.10M | 253.47M | 319.52M | 330.10M |
| Revenue Actual | 235.87M | 296.19M | 348.98M | 337.25M |
To track all earnings releases for Medifast visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
